All episodes

Ep. 115: Can we prevent dementia?

Ep. 115: Can we prevent dementia?

21m 35s

EAN moderator: Youssuf Saleh (Oxford, United Kingdom)
Guest: Sebastiaan Engelborghs (Brussel, Belgium)

In this episode Youssuf Saleh and Sebastiaan Engelborghs discuss dementia prevention, with particular reference to the recently published lancet commission report on dementia prevention, intervention and care. Key areas of discussion include what those risks are, how they can be mitigated and what adaptations the field of neurology and public health need to minimise the burden of dementia in aging populations.

Ep. 114: Neurological Prognosis and Treatment after Cardiac Arrest

Ep. 114: Neurological Prognosis and Treatment after Cardiac Arrest

28m 33s

EAN moderator: Marian Galovic (Zurich, Switzerland)

Guest: Michel van Putten (Enschede, The Netherlands)
In this episode, Marian Galovic talks with Prof. Michel van Putten about the effects of cardiac arrest on the brain. They highlight the role of EEG in assessing long-term prognosis following cardiac arrest and discuss the treatment of rhythmic or periodic EEG patterns.

Ep. 112: Brain Circuits: Principles and Translational Applications

Ep. 112: Brain Circuits: Principles and Translational Applications

26m 54s

EAN moderator: Youssuf Saleh (Oxford, United Kingdom)
Guest: Thanh Doan (Trondheim, Norway)

For this episodes Youssuf Saleh is joined by Thanh Doan as they discuss the role of brain circuits in neuroscience and how they can be used to advance both our understanding of disease and lay foundations for circuit-based treatments including neuromodulation.

Ep. 111: ECTRIMS-EAN Vaccination Consensus Statement

Ep. 111: ECTRIMS-EAN Vaccination Consensus Statement

32m 47s

EAN Moderator: Melinda Magyari (Copenhagen, Denmark)

Special Moderator: Brett Drummond (Melbourne, Australia)

Guest: Susana Otero (Barcelona, Spain)
In this episode eanCast: Weekly Neurology is joined by The ECTRIMS Podcast. Hosts Melinda Magyari and Brett Drummond talk about the ECTRIMS-EAN Vaccination Consensus Statement with lead author Susana Otero. Find the full article here.

Ep. 110: Family Planning Management in Multiple Sclerosis

Ep. 110: Family Planning Management in Multiple Sclerosis

21m 37s

Moderator: Melinda Magyari (Copenhagen, Denmark)

Guest: Celia Oreja-Guevara (Madrid, Spain)
In this last August episode Melinda Magyari hosts Celia Oreja-Guevara as they explore the impact of MS on women's fertility, the shift in advice regarding pregnancy, and how pregnancy affects MS activity. They also discuss the importance of consulting a neurologist, considerations for artificial reproduction techniques, and recommendations for disease-modifying therapies, including treating relapses during pregnancy and breastfeeding.

Ep. 109: The Impact of Aging on MS: Comorbidities, Polypharmacy and Disease Modifying Treatments

Ep. 109: The Impact of Aging on MS: Comorbidities, Polypharmacy and Disease Modifying Treatments

23m 30s

Moderator: Melinda Magyari (Copenhagen, Denmark)

Guest: Thomas Berger (Vienna, Austria)

Melinda Magyari and her guest Thomas Berger talk about how aging affects MS progression and management, focusing on immunosenescence's impact on the immune response and DMT effectiveness. They cover the rise of comorbidities in older MS patients, the challenges of using DMTs over age 55, the lack of clinical trials for this age group, and share lifestyle tips to improve quality of life and health outcomes.

Ep. 108: Central Vein Sign and Chronic Active Lesions: Relevance for Diagnosis and Prognosis in Multiple Sclerosis

Ep. 108: Central Vein Sign and Chronic Active Lesions: Relevance for Diagnosis and Prognosis in Multiple Sclerosis

27m 7s

Moderator: Melinda Magyari (Copenhagen, Denmark)
Guest: Nikolaos Grigoriadis (Thessaloniki, Greece)

Melinda Magyari hosts Paolo Preziosa as they delve into the significance of central vein sign and chronic active lesions in multiple sclerosis diagnosis and prognosis. They explore how these MRI biomarkers enhance diagnostic accuracy and predict disease progression, emphasizing their potential clinical relevance and the need for further research to optimize MS treatment strategies.

Ep. 107: Is EBV the Key Player in Multiple Sclerosis Pathogenesis?

Ep. 107: Is EBV the Key Player in Multiple Sclerosis Pathogenesis?

25m 32s

Moderator: Melinda Magyari (Copenhagen, Denmark)

Guest: Nikolaos Grigoriadis (Thessaloniki, Greece)

Follow Melinda Magyari and her guest Nikolaos Grigoriadis in the first MS episode of this month as they explore the Epstein-Barr Virus and its potential link to multiple sclerosis. They discuss how EBV might trigger or worsen MS, the challenges in confirming this connection, and implications for treatment and prevention. Other MS risk factors, such as genetics, environment, vitamin D levels, and lifestyle, are also covered.

Ep. 106: Phenoconversion in Pure Autonomic Failure

Ep. 106: Phenoconversion in Pure Autonomic Failure

28m 54s

Moderator: Anne Pavy-Le Traon (Toulouse, France)
Guests: Giovanna Calandra-Buonaura (Bologna, Italy) and Valeria Iodice (London, United Kingdom)

In this week’s podcast episode Anne Pavy-Le Traon hosts two guests, Giovanna Calandra Buonaura and Valeria Iodice, as they discuss a hot topic related to Phenoconversion in Pure Autonomic Failure (PAF). They highlight the natural history of PAF and the importance of recognising this disease as a possible prodromal/ premotor phase of other alpha synucleinopathies. They discuss novel clinical and multimodal biomarkers in early diagnosis of these disorders.